PubMed Central
metadata only
Early effects of a novel 5-HT(4) agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: the RESTAND study
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept#909245
- Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression#1044183
- Efficacy and safety of selective serotonin reuptake inhibitors for diabetes mellitus with depression: a systematic review and meta-analysis.#433783
- Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression#851070
- The Impact of Citicoline/Phosphatidylserine Supplementation on Cognitive Performance and Executive Functions in Mental Disorders: A Systematic Review of Controlled Trials.#422819
Record · ID 393169
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive